Global Liver Diseases Therapeutics Drugs Market Size, Status and Forecast 2022

October 2017 | 103 pages | ID: GB1FE032963EN
QYResearch

Abstracts

This report studies the global Liver Diseases Therapeutics Drugs market, analyzes and researches the Liver Diseases Therapeutics Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• F. Hoffmann-La Roche
• Gilead Sciences
• GlaxoSmithKline
• Johnson & Johnson
• Merck
• Achillion Pharmaceuticals
• AbbVie
• Angion Biomedica
• Bayer
• LG Life Sciences
• Phenex Pharmaceuticals
• ProMetic Life Sciences
• Raptor Pharmaceuticals
• Shenzhen Kangtai Biological Products
• Verva Pharmaceuticals

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Liver Diseases Therapeutics Drugs can be split into

• Oral
• Injection

Market segment by Application, Liver Diseases Therapeutics Drugs can be split into

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Liver Diseases Therapeutics Drugs Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF LIVER DISEASES THERAPEUTICS DRUGS

1.1 Liver Diseases Therapeutics Drugs Market Overview
  1.1.1 Liver Diseases Therapeutics Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Liver Diseases Therapeutics Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Liver Diseases Therapeutics Drugs Market by Type
  1.3.1 Oral
  1.3.2 Injection
1.4 Liver Diseases Therapeutics Drugs Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Clinics
  1.4.3 Other

2 GLOBAL LIVER DISEASES THERAPEUTICS DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Liver Diseases Therapeutics Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 F. Hoffmann-La Roche
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Gilead Sciences
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 GlaxoSmithKline
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Johnson & Johnson
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Merck
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Achillion Pharmaceuticals
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 AbbVie
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Angion Biomedica
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Bayer
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 LG Life Sciences
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Liver Diseases Therapeutics Drugs Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Phenex Pharmaceuticals
3.12 ProMetic Life Sciences
3.13 Raptor Pharmaceuticals
3.14 Shenzhen Kangtai Biological Products
3.15 Verva Pharmaceuticals

4 GLOBAL LIVER DISEASES THERAPEUTICS DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Liver Diseases Therapeutics Drugs Market Size by Type (2012-2017)
4.2 Global Liver Diseases Therapeutics Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Liver Diseases Therapeutics Drugs in Future
4.4 Top Consumer/End Users of Liver Diseases Therapeutics Drugs

5 UNITED STATES LIVER DISEASES THERAPEUTICS DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Liver Diseases Therapeutics Drugs Market Size (2012-2017)
5.2 United States Liver Diseases Therapeutics Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU LIVER DISEASES THERAPEUTICS DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Liver Diseases Therapeutics Drugs Market Size (2012-2017)
6.2 EU Liver Diseases Therapeutics Drugs Market Size and Market Share by Players (2016 and 2017)

7 JAPAN LIVER DISEASES THERAPEUTICS DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Liver Diseases Therapeutics Drugs Market Size (2012-2017)
7.2 Japan Liver Diseases Therapeutics Drugs Market Size and Market Share by Players (2016 and 2017)

8 CHINA LIVER DISEASES THERAPEUTICS DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Liver Diseases Therapeutics Drugs Market Size (2012-2017)
8.2 China Liver Diseases Therapeutics Drugs Market Size and Market Share by Players (2016 and 2017)

9 INDIA LIVER DISEASES THERAPEUTICS DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Liver Diseases Therapeutics Drugs Market Size (2012-2017)
9.2 India Liver Diseases Therapeutics Drugs Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA LIVER DISEASES THERAPEUTICS DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Liver Diseases Therapeutics Drugs Market Size (2012-2017)
10.2 Southeast Asia Liver Diseases Therapeutics Drugs Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Liver Diseases Therapeutics Drugs Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2017-2022)
  11.1.2 EU Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2017-2022)
  11.1.4 China Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2017-2022)
  11.1.5 India Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Liver Diseases Therapeutics Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Liver Diseases Therapeutics Drugs Market Size by Application (2017-2022)

12 LIVER DISEASES THERAPEUTICS DRUGS MARKET DYNAMICS

12.1 Liver Diseases Therapeutics Drugs Market Opportunities
12.2 Liver Diseases Therapeutics Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Liver Diseases Therapeutics Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Liver Diseases Therapeutics Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Liver Diseases Therapeutics Drugs Product Scope
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) (2012-2017)
Table Global Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Liver Diseases Therapeutics Drugs Market Share by Regions in 2016
Figure United States Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Liver Diseases Therapeutics Drugs Market Share by Type in 2016
Figure Oral Market Size (Million USD) and Growth Rate (2012-2017)
Figure Injection Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Liver Diseases Therapeutics Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Other
Figure Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Liver Diseases Therapeutics Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Liver Diseases Therapeutics Drugs Market Size Share by Players in 2016
Figure Liver Diseases Therapeutics Drugs Market Size Share by Players in 2017
Table F. Hoffmann-La Roche Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Gilead Sciences Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Gilead Sciences (2012-2017)
Figure Gilead Sciences Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Achillion Pharmaceuticals Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Achillion Pharmaceuticals (2012-2017)
Figure Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table AbbVie Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Angion Biomedica Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Angion Biomedica (2012-2017)
Figure Angion Biomedica Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Bayer Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table LG Life Sciences Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of LG Life Sciences (2012-2017)
Figure LG Life Sciences Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Phenex Pharmaceuticals Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Phenex Pharmaceuticals (2012-2017)
Figure Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table ProMetic Life Sciences Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of ProMetic Life Sciences (2012-2017)
Figure ProMetic Life Sciences Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Raptor Pharmaceuticals Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Raptor Pharmaceuticals (2012-2017)
Figure Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Shenzhen Kangtai Biological Products Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Shenzhen Kangtai Biological Products (2012-2017)
Figure Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Verva Pharmaceuticals Basic Information List
Table Liver Diseases Therapeutics Drugs Business Revenue (Million USD) of Verva Pharmaceuticals (2012-2017)
Figure Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Business Revenue Market Share in 2016
Table Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Type in 2012
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Type in 2013
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Type in 2014
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Type in 2015
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Type in 2016
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Type in 2017
Table Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application in 2012
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application in 2013
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application in 2014
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application in 2015
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application in 2016
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Liver Diseases Therapeutics Drugs
Figure United States Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Liver Diseases Therapeutics Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Liver Diseases Therapeutics Drugs Market Size Share by Players in 2016
Figure United States Liver Diseases Therapeutics Drugs Market Size Share by Players in 2017
Figure EU Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Liver Diseases Therapeutics Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Liver Diseases Therapeutics Drugs Market Size Share by Players in 2016
Figure EU Liver Diseases Therapeutics Drugs Market Size Share by Players in 2017
Figure Japan Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Liver Diseases Therapeutics Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Liver Diseases Therapeutics Drugs Market Size Share by Players in 2016
Figure Japan Liver Diseases Therapeutics Drugs Market Size Share by Players in 2017
Figure China Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Liver Diseases Therapeutics Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Liver Diseases Therapeutics Drugs Market Size Share by Players in 2016
Figure China Liver Diseases Therapeutics Drugs Market Size Share by Players in 2017
Figure India Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Liver Diseases Therapeutics Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Liver Diseases Therapeutics Drugs Market Size Share by Players in 2016
Figure India Liver Diseases Therapeutics Drugs Market Size Share by Players in 2017
Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Liver Diseases Therapeutics Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size Share by Players in 2016
Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size Share by Players in 2017
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Regions in 2017
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Regions in 2022
Figure United States Liver Diseases Therapeutics Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Liver Diseases Therapeutics Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Liver Diseases Therapeutics Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Liver Diseases Therapeutics Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Liver Diseases Therapeutics Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Liver Diseases Therapeutics Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Type in 2017
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Type in 2022
Table Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application in 2017
Figure Global Liver Diseases Therapeutics Drugs Market Size (Million USD) by Application in 2022